MedTrace Logo

Early Initiation of High-flow Nasal Cannula Oxygen Therapy in Patients With Acute Respiratory Failure in the Emergency Department: A Before-after Study

NCT03447457 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2018-02-27

No results posted yet for this study

Summary

The aim of the study is to compare the efficiency on respiratory failure regression of high-flow nasal oxygen therapy versus standard oxygen in patients admitted to the ED for de novo acute respiratory failure.

Conditions

  • Acute Respiratory Failure

Interventions

DEVICE

High-flow oxygen

HFNC is continuously applied via large-bore nasal prongs with a gas flow rate of 50 L/min and a FiO2 adjusted to maintain a pulse oxymetry at least 92%

DEVICE

Standard oxygen

nasal cannula, face mask or non-rebreathing reservoir mask

Sponsors & Collaborators

  • Centre Hospitalier de Niort

    collaborator OTHER

  • Poitiers University Hospital

    lead OTHER

Principal Investigators

  • Jean MACE, MD · Centre Hospitalier de Niort

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-01
Primary Completion
2017-05-30
Completion
2017-05-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03447457 on ClinicalTrials.gov